From Health Affairs Today <[email protected]>
Subject Trends In Medications For Opioid Use Disorder
Date January 17, 2024 9:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
📢 Applications for 2024-2025 HEFT Are Open 📢

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Wednesday, January 17, 2024 | The Latest Research, Commentary, and News from Health Affairs

Dear John,

FYI, applications for the 2024–2025 Health Equity Fellowship for Trainees cohort are open ([link removed] ) until February 15, 2024.

Find Out More
([link removed] )

Increases in Medications For Opioid Use Disorder in Louisiana

Louisiana has engaged in multiple efforts to expand access to medications for opioid use disorder (MOUD) to address the opioid crisis.

Among these efforts has been a requirement that residential treatment programs offer MOUD as a condition of licensure.

In the January issue of Health Affairs, Olivia Sugarman of Johns Hopkins University and her team of coauthors examine trends in MOUD use among Louisiana Medicaid enrollees diagnosed with OUD ([link removed] ) between 2018-21.

The researchers find during the study period, there was a nearly threefold increase in MOUD among patients treated in nonresidential treatment settings, and a fivefold increase for patients treated in residential settings.

They attribute most of this increase in MOUD use to greater use of buprenorphine.

Sugarman and coauthors also conclude that “MOUD use was highest among enrollees who were White, were older, had comorbidities, and lived in a metropolitan area,” and suggest that policies that promote greater access to MOUD in SUD facilities are critical to addressing the overdose crisis.

Read the Article
([link removed] )

health-affairs-events-memorable-2023_eNewsletter-banner ([link removed] )

With today's featured journal article focusing on opioid use disorder and disparities in access, the full story is just a few clicks away by exploring our archive of podcasts on these topics.

Take a look below at a few highlighted episodes:

- Health Affairs This Week: Getting Personal: Racism and Health Equity ([link removed] ) (November 2023)
- Research and Justice For All: Health Care Role in Health Equity ([link removed] ) (September 2023)
- A Health Podyssey: Julia Dennett on the Health Effects of OxyContin Marketing ([link removed] ) (August 2023)
- Health Affairs This Week: A Seat For All: Building Health Equity Into Scholarly Programs ([link removed] ) (March 2023)

The Inflation Reduction Act Coinsurance Glitch ([link removed] )

Mark V. Pauly et al.

health-affairs-scholar-top-10-2023_eNewsletter-banner ([link removed] )

health-affairs-43-01-order-issue_eNewsletter-banner ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs,1220 19th St. NW, Suite 800, Washington, DC, 20036, United States,

202-408-6801

Unsubscribe ([link removed] ) | Manage Preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis